All Updates

All Updates

icon
Filter
M&A
Augmedics acquires assets of bankrupt Surgalign for USD 0.9 million
Extended Reality
Aug 1, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Extended Reality

Extended Reality

Aug 1, 2023

Augmedics acquires assets of bankrupt Surgalign for USD 0.9 million

M&A

  • Augmedics, an AR surgical navigation platform, has acquired the digital health assets of Surgalign and Holo Surgical for USD 0.9 million in cash.

  • Surgalign's digital health offerings include the HOLO Portal, an AI-driven AR guidance system that provides intraoperative image-guided navigation of a patient's spine. The patented AR system enables a 3D overlay of the patient's anatomy and real-time superimposition of 3D targeting and trajectory on surgical instruments.

  • Augmedics plans to integrate these offerings with its own AR-based and AI-based solutions, including its FDA-cleared xvision platform.

  • Analyst QuickTake: The acquisition allows Augmedics to bolster its product offering, which announced the launch of a new set of FDA-cleared features to expand capabilities of its xvision platform in March 2023 . Augmedics also raised USD 82.5 million in a Series D funding round in June 2023 , with funding being utilized to expand Augmedics' US commercial footprint and enable mass-scale adoption of its proprietary xvision technology. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.